Red blood cell precursor mass as an independent determinant of serum erythropoietin level

Blood

Volumn 91, Issue 6, 1998, Pages 2139-2145

  Cazzola, Mario ^a,b   Guarnone, Roberta ^a   Cerani, Paola ^a   Centenara, Esther ^a   Rovati, Andrea ^a   Beguin, Yves ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Int Medicine and Medical Oncology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; TRANSFERRIN RECEPTOR;

ARTICLE; BETA THALASSEMIA; BONE MARROW APLASIA; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; ERYTHROCYTE APLASIA; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HEMATOCRIT; HUMAN; HUMAN CELL; HYPOXIA; IRON DEFICIENCY ANEMIA; KIDNEY FAILURE; PRIORITY JOURNAL;

EID: 0032520980     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.2139.2139_2139_2145     Document Type: Article

References (38)

1. Lacombe C, Da Silva JL, Bruneval P, Fournier JG, Wendling F, Casadevall N, Camilleri JP, Bariety J, Varet B, Tambourin P: Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidneys. J Clin Invest 81:620, 1988
2. Koury ST, Bondurant MC, Koury MJ: Localization of erythropoietin synthetizing cells in murine kidneys by in situ hybridization. Blood 71:524, 1988
3. Barosi G: Inadequate erythropoietin response to anemia. Definition and clinical relevance. Ann Hematol 68:215,
4. Beguin Y, Clemons G, Pootrakul P, Fillet G: Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 81:1067, 1993
5. Cazzola M, Mercuriali F, Brugnara C: Use of recombinant human erythropoietin outside the setting of uremia. Blood 89:4248, 1997
6. Cazzola M, Messinger D, Battistel V, Bron D, Cimmo R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B: Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: Dose finding and identification of predictors of response. Blood 86:4446, 1995
7. Cazzola M, Ponchio L, Pedrotti C, Farina G, Cerani P, Lucotti C, Novella A, Rovati A, Bergamaschi G, Beguin Y: Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy. Haematologica 81:434, 1996
8. Gaines Das RE, Milne A, Rowley M, Gordon-Smith EC, Cotes PM: Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemia. Br J Haematol 82:601, 1992
9. Schrezenmeier H, Noé G, Raghavacar A, Rich IN, Heimpel H, Kubanek B: Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia. Br J Haematol 88:286, 1994
10. Schapira L, Antin JH, Ransil BJ, Antman KH, Eder JP, McGarigle CJ, Goldberg MA: Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 76:2354, 1990
11. Birgegård G, Wide L, Simonsson B: Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation. Br J Haematol 72:462, 1989
12. Kendall RG, Cavill I, Norfolk DR: Serum erythropoietin levels during haematinic therapy. Br J Haematol 81:630, 1992 (letter)
13. Cazolla M, Beguin Y: New tools for clinical evaluation of erythropoiesis and iron status in man. Br J Haematol 80:278, 1992
14. Cazzola M, Guarnone R, Beguin Y: Red cell precursors mass as an independent determinant of serum erythropoietin level. Blood 88:348a, 1996 (suppl 1, abstr)
15. Beguin Y, Oris R, Fillet G: Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. Bone Marrow Transplant 11:285, 1993
16. Bothwell TH, Charlton RW, Cook JD, Finch CA: Iron Metabolism in Man. Oxford, Blackwell, 1979
17. Napier JAF: Blood Transfusion Therapy: A Problem-Oriented Approach. Chichester, Wiley, 1987
18. Martelli M, Ponchio L, Beguin Y, Meloni G, Mandelli F, Cazzola M: Pure red cell aplasia following peripheral stem cell transplantation: Complete response to a short course of high-dose recombinant human erythropoietin. Haematologica 79:456, 1994
19. Krantz SB: Erythropoietin. Blood 77:419, 1991
20. Ratcliffe PJ, Ebert BL, Firth JD, Gleadle JM, Maxwell PH, Nagao M, O'Rourke JF, Pugh CW, Wood SM: Oxygen regulated gene expression: Erythropoietin as a model system. Kidney Int 51:514, 1997
21. Faquin WC, Schneider TJ, Goldberg MA: Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79: 1987, 1992
22. Singh A, Eckardt KU, Zimmermann A, Götz KH, Hamann M, Ratcliffe PJ, Kurtz A, Reinhart WH: Increased plasma viscosity as a reason for inappropriate erythropoietin formation. J Clin Invest 91:251, 1993
23. Jacobs A, Janowska-Wieczorek A, Caro J, Bowden DT, Lewis T: Circulating erythropoietin in patients with myelodysplastic syndromes. Br J Haematol 73:36, 1989
24. Sherwood JB, Goldwasser E, Chilcote R, Carmichael LD, Nagel RL: Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood 67:46, 1986
25. Camaschella C, Gonella S, Calabrese R, Vischia F, Roetto A, Graziadei G, Mazza U, Cappellini MD: Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes. Haematologica 81:397, 1996
26. Remacha AF, Bellido M, Garcia-Die F, Marco N, Ubeda J, Gimferrer E: Serum erythropoietin and erythroid activity in vitamin B12 deficiency. Haematologica 82:67, 1997
27. Piroso E, Erslev AJ, Caro J: Inappropriate increase in erythropoietin titers during chemotherapy. Am J Hematol 32:248, 1989
28. Schapira L, Antin JH, Ransil BJ, Antman KH, Eder JP, McGarigle CJ, Goldberg MA: Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 76:2354, 1990
29. Grace RJ, Kendall RG, Chapman C, Hartley AE, Barnard DL, Norfolk DR: Changes in serum erythropoietin levels during allogeneic bone marrow transplantation. Eur J Haematol 47:81, 1991
30. Sawabe Y, Kikuno K, Iseki T, Lida S, Tabata Y, Yonemitsu H: Changes in serum erythropoietin and the reticulocyte count during chemotherapy for leukemias. Eur J Haematol 57:384, 1996
31. Kling PJ, Dragsten PR, Roberts RA, Dos Santos B, Brooks DJ, Hedlund BE, Taetle R: Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancy. Br J Haematol 95:241, 1996
32. Carmel R, MacPhee RD: Erythropoietin levels in cobalamin deficiency: Comparison of anemic and non-anemic, subtly deficient patients. Eur J Haematol 48:159, 1992
33. Piroso E, Erslev AJ, Flaharty KK, Caro J: Erythropoietin life span in rats with hypoplastic and hyperplastic bone marrows. Am J Haematol 36:105, 1991
34. Lezón C, Alippi RM, Barceló AC, Martinez MP, Conti MI, Bozzini CE: Depression of stimulated erythorpoietin production in mice with enhanced erythropoiesis. Haematologica 80:491, 1995
35. Nagata Y, Shozaki Y, Nagahisa H, Natasawa T, Abe T, Todokoro K: Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb Haemost 77:808, 1997
36. Guarnone R, Centenara E, Zappa M, Zanella A, Barosi G: Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis. Br J Haematol 92:150, 1996
37. Erslev AJ: The effect of hemolysates on red cell production and erythropoietin release. J Lab Clin Med 78:1, 1971
38. Bergamaschi G, Recalde HR, Ponchio L, Rosti V, Cazzola M: Erythrophagocytosis increases the expression of erythroid potentiating activity (EPA) and mRNA in human monocyte-macrophages. Exp Haematol 21:70, 1993